Emergent BioSolutions Inc. — Director's Dealing 2020

Feb 25, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2020-02-21

Reporting Person: Richard Ronald (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-21	Common Stock	M	5152	$18.64	Acquired	31851	Direct
2020-02-21	Common Stock	S	5152	$65	Disposed	16395	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-21	Employee Stock Options (Right to Buy)	$18.64	M	5152	Disposed	2021-05-21	Common Stock (5152.0)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard.

F2: Consists of an option granted under the company's stock incentive plan as amended and restated.

F3: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. The date herein represents the third anniversary date of the grant and the final vesting date.